$CTRN
Citi Trends Inc

2024 Q1 Form 10-K Financial Statement

#000155837023005840 Filed on April 13, 2023

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q2 2023 Q1
Revenue $215.2M $179.7M $209.5M
YoY Change 2.73% -13.7% -13.08%
Cost Of Revenue $131.0M $113.7M $126.7M
YoY Change 3.41% -10.51% -11.82%
Gross Profit $84.18M $66.03M $82.78M
YoY Change 1.69% -18.69% -14.94%
Gross Profit Margin 39.12% 36.75% 39.52%
Selling, General & Admin $74.53M $70.81M $70.58M
YoY Change 5.6% -0.31% -11.29%
% of Gross Profit 88.53% 107.24% 85.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.850M $4.681M $4.802M
YoY Change 1.0% -14.03% -7.21%
% of Gross Profit 5.76% 7.09% 5.8%
Operating Expenses $79.38M $75.49M $75.38M
YoY Change 5.3% 6.28% -11.04%
Operating Profit $4.804M -$9.459M $7.400M
YoY Change -35.08% -123.85% -41.16%
Interest Expense $992.0K $948.0K $754.0K
YoY Change 31.56% 1147.37% -861.62%
% of Operating Profit 20.65% 10.19%
Other Income/Expense, Net
YoY Change
Pretax Income $4.923M -$8.511M $8.154M
YoY Change -39.62% -121.5% -34.65%
Income Tax $1.372M -$1.876M $1.517M
% Of Pretax Income 27.87% 18.6%
Net Earnings $3.551M -$6.635M $6.637M
YoY Change -46.5% -121.97% -32.54%
Net Earnings / Revenue 1.65% -3.69% 3.17%
Basic Earnings Per Share -$0.81
Diluted Earnings Per Share $0.42 -$0.81 $0.81
COMMON SHARES
Basic Shares Outstanding 8.313M
Diluted Shares Outstanding 8.182M

Balance Sheet

Concept 2024 Q1 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $79.71M $88.71M $103.5M
YoY Change -22.99% 43.87% 107.87%
Cash & Equivalents $103.5M $88.71M $49.79M
Short-Term Investments
Other Short-Term Assets $10.84M $16.05M $13.59M
YoY Change -20.26% -1.83% -9.37%
Inventory $130.4M $114.3M $105.8M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $221.0M $219.1M $222.9M
YoY Change -0.85% 5.47% 15.72%
LONG-TERM ASSETS
Property, Plant & Equipment $287.5M $309.8M $317.3M
YoY Change -9.39% 354.19% 321.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.23M $5.529M $4.076M
YoY Change 151.05% 329.6% 209.49%
Total Long-Term Assets $297.7M $315.3M $321.4M
YoY Change -7.35% -0.05% 14.2%
TOTAL ASSETS
Total Short-Term Assets $221.0M $219.1M $222.9M
Total Long-Term Assets $297.7M $315.3M $321.4M
Total Assets $518.7M $534.4M $544.3M
YoY Change -4.69% 2.14% 14.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.4M $90.03M $80.67M
YoY Change 24.42% 2.47% -18.42%
Accrued Expenses $69.15M $71.25M $79.54M
YoY Change -13.06% 217.54% 447.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $169.9M $162.2M $160.6M
YoY Change 5.82% -7.86% -14.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $191.1M $212.3M $217.3M
YoY Change -12.04% 9750.3% 10226.09%
Total Long-Term Liabilities $191.1M $212.3M $217.3M
YoY Change -12.04% 9750.3% 10226.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $169.9M $162.2M $160.6M
Total Long-Term Liabilities $191.1M $212.3M $217.3M
Total Liabilities $361.0M $374.5M $377.8M
YoY Change -4.45% -1.98% 5.57%
SHAREHOLDERS EQUITY
Retained Earnings $319.1M $324.4M $331.1M
YoY Change -3.62% 7.29% 21.64%
Common Stock $105.8M $102.8M $102.6M
YoY Change 3.16% 1.39% 1.39%
Preferred Stock
YoY Change
Treasury Stock (at cost) $267.2M $267.2M $267.2M
YoY Change 0.0% 1.78% 3.89%
Treasury Stock Shares
Shareholders Equity $157.7M $160.0M $166.4M
YoY Change
Total Liabilities & Shareholders Equity $518.7M $534.4M $544.3M
YoY Change -4.69% 2.14% 14.82%

Cashflow Statement

Concept 2024 Q1 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $3.551M -$6.635M $6.637M
YoY Change -46.5% -121.97% -32.54%
Depreciation, Depletion And Amortization $4.850M $4.681M $4.802M
YoY Change 1.0% -14.03% -7.21%
Cash From Operating Activities $23.29M -$13.06M $28.81M
YoY Change -19.16% -30.85% 48.02%
INVESTING ACTIVITIES
Capital Expenditures $3.307M $950.0K $3.069M
YoY Change 7.75% -111.86% -134.49%
Acquisitions
YoY Change
Other Investing Activities -$1.000K $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.308M -$950.0K -$3.069M
YoY Change 7.79% -102.49% -111.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.000K -783.0K -20.00K
YoY Change -85.0% -89.48% -99.76%
NET CHANGE
Cash From Operating Activities 23.29M -13.06M 28.81M
Cash From Investing Activities -3.308M -950.0K -3.069M
Cash From Financing Activities -3.000K -783.0K -20.00K
Net Change In Cash 19.98M -14.79M 25.72M
YoY Change -22.33% -224.59% -31.88%
FREE CASH FLOW
Cash From Operating Activities $23.29M -$13.06M $28.81M
Capital Expenditures $3.307M $950.0K $3.069M
Free Cash Flow $19.98M -$14.01M $25.74M
YoY Change -22.37% 28.88% -9.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2022 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2023 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#ProductMember
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-28
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001318484
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-28
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-51315
CY2023 dei Entity Registrant Name
EntityRegistrantName
CITI TRENDS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2150697
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
104 Coleman Boulevard
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Savannah
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
31408
CY2023 dei City Area Code
CityAreaCode
912
CY2023 dei Local Phone Number
LocalPhoneNumber
236-1561
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $.01 Par Value
CY2023 dei Trading Symbol
TradingSymbol
CTRN
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q3 dei Entity Public Float
EntityPublicFloat
205965947
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8313268
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche LLP
CY2023 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103495000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2023Q1 us-gaap Inventory Net
InventoryNet
105794000
CY2022Q1 us-gaap Inventory Net
InventoryNet
123835000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12977000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14997000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
615000
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3987000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
222881000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
192607000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60106000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75282000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
257195000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
201827000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2893000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2992000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1183000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1317000
CY2023Q1 us-gaap Assets
Assets
544258000
CY2022Q1 us-gaap Assets
Assets
474025000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
80670000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
98879000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52661000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47803000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16055000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14532000
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
10823000
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
25896000
CY2023Q1 us-gaap Deferred Income
DeferredIncome
344000
CY2022Q1 us-gaap Deferred Income
DeferredIncome
364000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
160553000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
187474000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
214939000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168304000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2322000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2104000
CY2023Q1 us-gaap Liabilities
Liabilities
377814000
CY2022Q1 us-gaap Liabilities
Liabilities
357882000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16158494
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16090365
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8354481
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8617210
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
160000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
159000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102445000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
101037000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
331050000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
272158000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7804013
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7473155
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
267211000
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
257211000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
166444000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
116143000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
544258000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
474025000
CY2023 us-gaap Revenues
Revenues
795011000
CY2022 us-gaap Revenues
Revenues
991595000
CY2021 us-gaap Revenues
Revenues
783294000
CY2023 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
484022000
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
584063000
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
471618000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
279177000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
307622000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
260198000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20595000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20393000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19259000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
286000
CY2023 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
64088000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
75305000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
79517000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
31933000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1034000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
31000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
CY2023 us-gaap Interest Expense
InterestExpense
306000
CY2022 us-gaap Interest Expense
InterestExpense
306000
CY2021 us-gaap Interest Expense
InterestExpense
776000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76033000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79242000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31395000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17141000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
58892000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62240000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23978000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.17
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.98
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.33
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.17
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.91
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.32
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8216000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8912000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10283000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8216000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9013000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10325000
CY2023 us-gaap Profit Loss
ProfitLoss
58892000
CY2022 us-gaap Profit Loss
ProfitLoss
62240000
CY2021 us-gaap Profit Loss
ProfitLoss
23978000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20595000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20393000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19259000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
51310000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50455000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
48242000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
286000
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-10000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-201000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-39000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
99000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3203000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
474000
CY2023 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
1575000
CY2022 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
804000
CY2021 ctrn Insurance Proceeds From Operating Activities
InsuranceProceedsFromOperatingActivities
1042000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
3635000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4776000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2912000
CY2023 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
64088000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16826000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20381000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33564000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1660000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2011000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7718000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-134000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
278000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
14000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18329000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12833000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5083000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-54844000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53187000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-38346000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15073000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
16302000
CY2023 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
3372000
CY2022 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-8610000
CY2021 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
5809000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-20000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-136000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5754000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74319000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
110858000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
35272000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
43759000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
35272000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
522000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22287000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
29707000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
16956000
CY2023 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
1370000
CY2022 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
192000
CY2021 ctrn Insurance Proceeds From Investing Activities
InsuranceProceedsFromInvestingActivities
416000
CY2023 us-gaap Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity
ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
81098000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60181000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29515000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26697000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
43700000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
43700000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
270000
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2228000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2638000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
608000
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
832000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10000000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
115285000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
32861000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12228000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-118193000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34301000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
53707000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-73389000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103254000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123177000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19923000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103495000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49788000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123177000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
158000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
176000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
731000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13842000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22409000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1134000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1522000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2847000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1392000
CY2022 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3415000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
171044000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2912000
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
608000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
32861000
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
832000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
23978000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
163634000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2022 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3415000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4776000
CY2022 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2638000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
115285000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62240000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
116143000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3635000
CY2023 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2228000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
58892000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
166444000
CY2023 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Helvetica';font-size:9.5pt;font-weight:bold;">1. Organization and Business</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0.05pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">Citi Trends, Inc. and its subsidiary (the “Company”) is a leading specialty value retailer of apparel, accessories and home trends for way less spend primarily for African American and multicultural families in the United States. As of January 28, 2023, the Company operated </span><span style="font-family:'Helvetica';font-size:9.5pt;">611</span><span style="font-family:'Helvetica';font-size:9.5pt;"> stores in urban, suburban and rural markets in </span><span style="font-family:'Helvetica';font-size:9.5pt;">33</span><span style="font-family:'Helvetica';font-size:9.5pt;"> states.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0.05pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The COVID-19 pandemic and related government stimulus caused significant volatility and disruptions in our business during fiscal 2020 and 2021. Certain lingering economic effects of the pandemic, such as supply chain disruptions, continued to impact results in fiscal 2022. T</span><span style="font-family:'Helvetica';font-size:9.5pt;">he Company</span><span style="font-family:'Helvetica';font-size:9.5pt;"> cannot reasonably predict the extent to which our future business will be impacted by the pandemic. </span></p>
CY2023Q1 us-gaap Number Of Stores
NumberOfStores
611
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
CY2023 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;font-style:italic;font-weight:bold;">Fiscal Year</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;min-height:1.15pt;margin:0pt 0pt 8pt 0.05pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The Company’s fiscal year ends on the Saturday closest to January 31 of each year. The years ended January 28, 2023, January 29, 2022 and January 30, 2021 are referred to as fiscal 2022, fiscal 2021 and fiscal 2020, respectively, in the accompanying consolidated financial statements. Fiscal 2022, 2021 and 2020 are all comprised of </span><span style="font-family:'Helvetica';font-size:9.5pt;">52</span><span style="font-family:'Helvetica';font-size:9.5pt;"> weeks. </span></p>
CY2021 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2022 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2023 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and apply judgments that affect the reported amounts. Actual results could differ from those estimates.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;min-height:1.15pt;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Helvetica';font-size:9.5pt;">The most significant estimates include those used in the valuation of inventory, property and equipment, self-insurance liabilities, leases and income taxes. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively.</span></p>
CY2023Q1 ctrn Allowances For Inventory Shrinkage
AllowancesForInventoryShrinkage
5800000
CY2022Q1 ctrn Allowances For Inventory Shrinkage
AllowancesForInventoryShrinkage
4400000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6593000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2738000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2936000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1777000
CY2023 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
-268000
CY2022 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
152000
CY2023 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2022 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
300000
CY2023 ctrn Self Insured Maximum Retention Or Deductible Amount Each Claim Under Workers Compensation
SelfInsuredMaximumRetentionOrDeductibleAmountEachClaimUnderWorkersCompensation
250000
CY2023 ctrn Self Insured Maximum Retention Or Deductible Amount Each Claim Under Employee Medical
SelfInsuredMaximumRetentionOrDeductibleAmountEachClaimUnderEmployeeMedical
100000
CY2021 ctrn Income Tax Reconciliation Tax Credits State
IncomeTaxReconciliationTaxCreditsState
168000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-393000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-158000
CY2023 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
1871000
CY2022 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
1433000
CY2021 ctrn Income Tax Reconciliation Tax Credits General Business
IncomeTaxReconciliationTaxCreditsGeneralBusiness
878000
CY2023 ctrn Effective Income Tax Rate Reconciliation Nondeductible Compensation Expense Amount
EffectiveIncomeTaxRateReconciliationNondeductibleCompensationExpenseAmount
44000
CY2023 ctrn Period Customers Can Return Merchandise
PeriodCustomersCanReturnMerchandise
P30D
CY2023Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
300000
CY2022Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
200000
CY2022Q1 us-gaap Contract With Customer Right To Recover Product Current
ContractWithCustomerRightToRecoverProductCurrent
100000
CY2022 ctrn Effective Income Tax Rate Reconciliation Nondeductible Compensation Expense Amount
EffectiveIncomeTaxRateReconciliationNondeductibleCompensationExpenseAmount
455000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
507000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-1226000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
58000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-119000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-61000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
35000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17141000
CY2023 ctrn Distribution Center Costs
DistributionCenterCosts
26300000
CY2022 ctrn Distribution Center Costs
DistributionCenterCosts
24900000
CY2021 ctrn Distribution Center Costs
DistributionCenterCosts
20300000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8216448
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8911810
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10282718
CY2022 ctrn Incremental Common Shares Attributable To Vesting Of Nonvested Restricted Stock
IncrementalCommonSharesAttributableToVestingOfNonvestedRestrictedStock
101122
CY2021 ctrn Incremental Common Shares Attributable To Vesting Of Nonvested Restricted Stock
IncrementalCommonSharesAttributableToVestingOfNonvestedRestrictedStock
42521
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8216448
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9012932
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10325239
CY2023 us-gaap Advertising Expense
AdvertisingExpense
800000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
1200000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1600000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2023Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1627000
CY2022Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1910000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
911000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
781000
CY2023Q1 ctrn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
67075000
CY2022Q1 ctrn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
55088000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
322631000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
358727000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
262525000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
283445000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60106000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75282000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
12616000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
11326000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5538000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4426000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2473000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1405000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17042000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13799000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6943000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1031000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2629000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
588000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-932000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
574000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-114000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
99000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3203000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
474000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17141000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17002000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7417000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15967000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
16641000
CY2023Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2765000
CY2022Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3033000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1178000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2233000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
972000
CY2022Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
778000
CY2023Q1 ctrn Deferred Tax Assets Tax Deferred Expense Research And Development
DeferredTaxAssetsTaxDeferredExpenseResearchAndDevelopment
811000
CY2023Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
605000
CY2022Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
620000
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
75944000
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64443000
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1163000
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1556000
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
74781000
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
62887000
CY2023Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
65130000
CY2022Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
53342000
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
5798000
CY2022Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
5574000
CY2023Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
960000
CY2022Q1 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
979000
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
71888000
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
59895000
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2893000
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2992000
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023 ctrn Tax Credit Carryforward Valuation Allowance Number Of States
TaxCreditCarryforwardValuationAllowanceNumberOfStates
1
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1200000
CY2023 ctrn Tax Credit Carryback Period
TaxCreditCarrybackPeriod
P1Y
CY2023 ctrn Tax Credit Carryforward Period
TaxCreditCarryforwardPeriod
P20Y
CY2023 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1600000
CY2022 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1600000
CY2021 ctrn Income Tax Benefit Related To Federal And State Tax Credits
IncomeTaxBenefitRelatedToFederalAndStateTaxCredits
1700000
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
331000
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1369000
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1031000
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
30.22
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
84.23
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
31.87
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
115285000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
32861000
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000.0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
610968
CY2023 ctrn Conversion Of Nonvested Cash Settled Units To Nonvested Shares Under Incentive Plan
ConversionOfNonvestedCashSettledUnitsToNonvestedSharesUnderIncentivePlan
3400000
CY2023 us-gaap Professional Fees
ProfessionalFees
100000
CY2023Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
60167000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
52737000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
50446000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
9911000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
10938000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
8159000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1395000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1091000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1459000
CY2023 us-gaap Lease Cost
LeaseCost
71473000
CY2022 us-gaap Lease Cost
LeaseCost
64766000
CY2021 us-gaap Lease Cost
LeaseCost
60064000
CY2023 ctrn Rent Abatements Due To Number Of Leases Agreements Renegotiated
RentAbatementsDueToNumberOfLeasesAgreementsRenegotiated
300000
CY2022 ctrn Rent Abatements Due To Number Of Leases Agreements Renegotiated
RentAbatementsDueToNumberOfLeasesAgreementsRenegotiated
700000
CY2023 ctrn Accrued Lease Liabilities Of Rent Abatement Agreements Renegotiated
AccruedLeaseLiabilitiesOfRentAbatementAgreementsRenegotiated
200000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
63866000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
56587000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
46147000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
35626000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
25574000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
119343000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
347143000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
79543000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
267600000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
56053000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
56932000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
47075000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
101241000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
75359000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
60144000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M29D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M25D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M13D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0449
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0286
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0311

Files In Submission

Name View Source Status
0001558370-23-005840-index-headers.html Edgar Link pending
0001558370-23-005840-index.html Edgar Link pending
0001558370-23-005840.txt Edgar Link pending
0001558370-23-005840-xbrl.zip Edgar Link pending
ctrn-20230128.xsd Edgar Link pending
ctrn-20230128x10k.htm Edgar Link pending
ctrn-20230128x10k001.jpg Edgar Link pending
ctrn-20230128xex21d1.htm Edgar Link pending
ctrn-20230128xex23d1.htm Edgar Link pending
ctrn-20230128xex23d2.htm Edgar Link pending
ctrn-20230128xex31d1.htm Edgar Link pending
ctrn-20230128xex31d2.htm Edgar Link pending
ctrn-20230128xex32d1.htm Edgar Link pending
ctrn-20230128xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
ctrn-20230128_def.xml Edgar Link unprocessable
ctrn-20230128_lab.xml Edgar Link unprocessable
ctrn-20230128_pre.xml Edgar Link unprocessable
ctrn-20230128x10k_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctrn-20230128_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable